172 filings
Page 3 of 9
UPLOAD
gcda8oca
15 Dec 22
Letter from SEC
12:00am
6-K
gadfw39xl8f2411df
9 Dec 22
Aptorum Group Announces Offering of $3 Million Convertible Note due 2023
7:00am
CORRESP
6bjczc
2 Dec 22
Correspondence with SEC
12:00am
UPLOAD
vaetjyphvs4ji7 43ayi
22 Nov 22
Letter from SEC
12:00am
6-K
udmy3 gmttd
18 Nov 22
Aptorum Group Limited Received Nasdaq Notification Letter Regarding Bid Price Deficiency
5:15pm
6-K
98a3mg9s5ddvmqd3rz7
8 Nov 22
Report of Foreign Private Issuer
6:00am
6-K
87yqetaswkggx5d5
30 Sep 22
Report of Foreign Private Issuer
4:01pm
6-K
10uuf
15 Sep 22
Aptorum Group Updates on the Clinical Validation of RPIDD Infectious Disease Liquid Biopsy Molecular Diagnostics
8:37am
6-K
foshvewlnh
11 Jul 22
Report of Foreign Private Issuer
4:30pm
6-K
azd6is32 kwi3jmy0a
9 Jun 22
Current Report
4:08pm
EFFECT
wxxjx y87e0fqtypxqjd
7 Jun 22
Notice of effectiveness
12:15am
POS AM
8rlo7
1 Jun 22
Prospectus update (post-effective amendment)
4:30pm
6-K
wmvvtci3avejvggeq
31 May 22
Report of Foreign Private Issuer
4:03pm
6-K
vysqa v03f
29 Apr 22
Aptorum Group Limited Reports 2021 Fiscal Year End Financial Results and Provides Business Update
4:01pm
6-K
sg9xfqx9fsx7tf
10 Jan 22
Report of Foreign Private Issuer
8:02am
6-K
ey2deyp
3 Dec 21
Aptorum Group Limited Announces Results of 2021 Annual General Meeting of Shareholders
8:00am
6-K
kpbw1z2c0wf4i6ssf
17 Nov 21
Report of Foreign Private Issuer
4:01pm
6-K
o99pa wcmm
19 Oct 21
Report of Foreign Private Issuer
8:00am
6-K
857j ajav1j04md
15 Sep 21
Report of Foreign Private Issuer
8:01am